The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1636-1640

  Sun, Xiaodong ^a   Han, Fang ^a   Yi, Junling ^b   Hou, Ningning ^a   Cao, Zhibin ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

Diabetes mellitus; Telomerase; Vascular smooth muscle cell

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; OLIGORIBONUCLEOTIDE; TELOMERASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGORIBONUCLEOTIDES; RATS; RATS, WISTAR; TELOMERASE; TRIGLYCERIDES;

RATTUS NORVEGICUS;

EID: 84876007266     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1350     Document Type: Article

References (26)

1. Bruemmer D and Law RE: Thiazolidinedione regulation of smooth muscle cell proliferation. Am J Med 115: 87-92, 2003.
2. Carmody BJ, Arora S, Wakefield MC, Weber M, Fox CJ and Sidawy AN: Progesterone inhibits human infragenicular arterial smooth muscle cell proliferation induced by high glucose and insulin concentrations. J Vasc Surg 36: 833-838, 2002.
3. Cifarelli V, Luppi P, Tse HM, He J, Piganelli J and Trucco M: Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-κB activation in vascular smooth muscle cells. Atherosclerosis 201: 248-257, 2008.
4. Isenović ER, Kedees MH, Tepavcević S, Milosavljević T, Korićanac G, Trpković A and Marche P: Role of PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation of vascular smooth muscle cells proliferation. Cardiovasc Hematol Disord Drug Targets 9: 172-180, 2009.
5. Gizard F, Nomiyama T, Zhao Y, et al: The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation. Circ Res 103: 1155-1163, 2008.
6. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L and Williams B: Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res 102: 201-208, 2008.
7. Jacob T, Hingorani A and Ascher E: Evidence for telomerase activation in VSMCs exposed to hyperglycemic and hyperhomocysteinemic conditions. Angiology 60: 562-568, 2009.
8. Serrano AL and Andrés V: Telomeres and cardiovascular disease: does size matter? Circ Res 94: 575-584, 2004.
9. Gancarcíková M, Zemanová Z, Brezinová J, Berková A, Vcelíková S, Smigová J and Michalová K: The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease. Prague Med Rep 111: 91-105, 2010.
10. Jones CH, Pepper C and Baird DM: Telomere dysfunction and its role in haematological cancer. Br J Haematol 156: 573-587, 2012.
11. Sprouse AA, Steding CE and Herbert BS: Pharmaceutical regulation of telomerase and its clinical potential. J Cell Mol Med 16: 1-7, 2012.
12. Cesselli D, Beltrami AP, D'Aurizio F, et al: Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 179: 349-366, 2011.
13. El Assar M, Angulo J, Vallejo S, Peiró C, Sánchez-Ferrer CF and Rodríguez-Mañas L: Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol 3: 132, 2012.
14. Fyhrquist F and Saijonmaa O: Telomere length and cardiovascular aging. Ann Med 44 (Suppl 1): S138-S142, 2012.
15. Cao Y, Li H, Mu FT, Ebisui O, Funder JW and Liu JP: Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J 16: 96-98, 2002.
16. Coppey LJ, Davidson EP, Rinehart TW, Gellett JS, Oltman CL, Lund DD and Yorek MA: ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 55: 341-348, 2006.
17. Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li YJ and Fu ZW: Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr 16 (Suppl 1): 412-417, 2007.
18. Wang Y, Qiao L, Qiu J, Mi W, Han Y and Zhong C: Establishing primary cultures of vascular smooth muscle cells from the spiral modiolar artery. Int J Pediatr Otorhinolaryngol 76: 1082-1086, 2012.
19. He X, Qiao Q, Ge N, et al: Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population. BMC Cancer 10: 312, 2010.
20. Huang J, Li LS, Yang DL, Gong QH, Deng J and Huang XN: Inhibitory effect of ginsenoside rg1 on vascular smooth muscle cell proliferation induced by PDGF-BB is involved in nitric oxide formation. Evid Based Complement Alternat Med 2012: 314395, 2012.
21. McMurray HF, Parrott DP and Bowyer DE: A standardised method of culturing aortic explants, suitable for the study of factors affecting the phenotypic modulation, migration and proliferation of aortic smooth muscle cells. Atherosclerosis 86: 227-237, 1991.
22. Sun X, Han F, Yi J, Han L and Wang B: Effect of aspirin on the expression of hepatocyte NF-kappaB and serum TNF-alpha in streptozotocin-induced type 2 diabetic rats. J Korean Med Sci 26: 765-770, 2011.
23. Jacob T, Clouden N, Hingorani A and Ascher E: The effect of cotinine on telomerase activity in human vascular smooth muscle cells. J Cardiovasc Surg (Torino) 50: 345-349, 2009.
24. Belair CD, Yeager TR, Lopez PM and Reznikoff CA: Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677-13682, 1997.
25. Matthews C, Gorenne I, Scott S, et al: Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 99: 156-164, 2006.
26. Chen H, Li Y and Tollefsbol TO: Strategies targeting telomerase inhibition. Mol Biotechnol 41: 194-199, 2009.